Brian T. Garibaldi

7.9k total citations · 3 hit papers
105 papers, 3.2k citations indexed

About

Brian T. Garibaldi is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Brian T. Garibaldi has authored 105 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Infectious Diseases, 24 papers in Pulmonary and Respiratory Medicine and 24 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Brian T. Garibaldi's work include COVID-19 Clinical Research Studies (19 papers), Innovations in Medical Education (19 papers) and Clinical Reasoning and Diagnostic Skills (17 papers). Brian T. Garibaldi is often cited by papers focused on COVID-19 Clinical Research Studies (19 papers), Innovations in Medical Education (19 papers) and Clinical Reasoning and Diagnostic Skills (17 papers). Brian T. Garibaldi collaborates with scholars based in United States, United Kingdom and Canada. Brian T. Garibaldi's co-authors include Yulin Hswen, Douglas L. Kriner, John S. Brownstein, Baobao Zhang, Sarah Kreps, Sandip M. Prasad, Sabra L. Klein, Cunjin Wu, Joseph B. Margolick and Taisheng Li and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Brian T. Garibaldi

93 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Aging in COVID-19: Vulnerability, immunity and intervention

2020 608 citations Sabra L. Klein, Brian T. Garibaldi et al. profile →
Factors Associated With US Adults’ Likelihood of Accepting COVID-19 Vaccination

2020 540 citations Brian T. Garibaldi et al. profile →
Racial and Ethnic Discrepancy in Pulse Oximetry and Delayed Identification of Treatment Eligibility Among Patients With COVID-19

2022 153 citations Kunbo Wang, Matthew L. Robinson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian T. Garibaldi United States	25	1.3k	604	479	477	394	105	3.2k
Rabih Halwani Saudi Arabia	40	1.3k 1.0×	307 0.5×	548 1.1×	881 1.8×	1.0k 2.6×	194	5.1k
Yitshak Kreiss Israel	26	1.6k 1.2×	483 0.8×	276 0.6×	107 0.2×	142 0.4×	82	3.1k
Hilda Razzaghi United States	28	1.2k 0.9×	1.0k 1.7×	373 0.8×	381 0.8×	111 0.3×	65	4.9k
Esteban Ortiz‐Prado Ecuador	20	779 0.6×	154 0.3×	249 0.5×	165 0.3×	181 0.5×	177	2.3k
Wan‐Ting Huang Taiwan	27	663 0.5×	245 0.4×	148 0.3×	309 0.6×	126 0.3×	117	2.9k
Anders Hviid Denmark	40	1.5k 1.2×	1.2k 2.0×	344 0.7×	342 0.7×	571 1.4×	159	6.8k
Malcolm G. Semple United Kingdom	30	1.4k 1.1×	144 0.2×	209 0.4×	460 1.0×	212 0.5×	121	3.0k
Michelle M. Hughes United States	21	1.7k 1.3×	553 0.9×	553 1.2×	464 1.0×	60 0.2×	40	4.0k
Tom T. Shimabukuro United States	37	2.5k 2.0×	1.6k 2.7×	342 0.7×	128 0.3×	287 0.7×	92	4.8k
Dongchi Zhao China	19	1.4k 1.1×	92 0.2×	285 0.6×	298 0.6×	295 0.7×	50	4.0k

Countries citing papers authored by Brian T. Garibaldi

Since Specialization

Citations

This map shows the geographic impact of Brian T. Garibaldi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian T. Garibaldi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian T. Garibaldi more than expected).

Fields of papers citing papers by Brian T. Garibaldi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian T. Garibaldi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian T. Garibaldi. The network helps show where Brian T. Garibaldi may publish in the future.

Co-authorship network of co-authors of Brian T. Garibaldi

This figure shows the co-authorship network connecting the top 25 collaborators of Brian T. Garibaldi. A scholar is included among the top collaborators of Brian T. Garibaldi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian T. Garibaldi. Brian T. Garibaldi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Garibaldi, Brian T., et al.. (2025). Avoiding the Storm: Recommended Practices for Building Cross-Institutional Teams and Collaboration in Graduate Medical Education. Journal of Graduate Medical Education. 17(2s). 32–36.

Garibaldi, Brian T. & Stephen W. Russell. (2025). Strategies to Reinvigorate the Bedside Clinical Encounter. New England Journal of Medicine. 393(21). 2142–2150.

Perin, Jamie, et al.. (2024). Effectiveness of Dexamethasone for COVID-19 in Hospitalized Patients With Diabetes: A Retrospective Cohort Study. The Journal of Clinical Endocrinology & Metabolism. 110(7). 1846–1853.

Deal, Jennifer A., Joshua Betz, Gwendolyn Clemens, et al.. (2023). COVID-19 clinical outcomes by patient disability status: A retrospective cohort study. Disability and health journal. 16(2). 101441–101441. 8 indexed citations

Garibaldi, Brian T., et al.. (2023). Internal medicine intern performance on the gastrointestinal physical exam. Diagnosis. 10(4). 412–416. 2 indexed citations

Robinson, Matthew L., C. Paul Morris, Joshua Betz, et al.. (2022). Impact of Severe Acute Respiratory Syndrome Coronavirus 2 Variants on Inpatient Clinical Outcome. Clinical Infectious Diseases. 76(9). 1539–1549. 17 indexed citations

Andersen, Kathleen M., Hemalkumar B. Mehta, Michael B. Streiff, et al.. (2022). Thromboprophylaxis in people hospitalized with COVID‐19: Assessing intermediate or standard doses in a retrospective cohort study. Research and Practice in Thrombosis and Haemostasis. 6(5). e12753–e12753. 1 indexed citations

Hynes, Noreen A., et al.. (2022). The Use of Temperature and Pressure Data Loggers to Validate the Steam Sterilization of Category A Clinical Waste. Applied Biosafety. 27(2). 106–115.

Scully, Eileen P., Guido Massaccesi, John Muschelli, et al.. (2021). Sex and Gender Differences in Testing, Hospital Admission, Clinical Presentation, and Drivers of Severe Outcomes From COVID-19. Open Forum Infectious Diseases. 8(9). ofab448–ofab448. 39 indexed citations

10.

Su, Hao, et al.. (2021). Physical human–robot interaction for clinical care in infectious environments. Nature Machine Intelligence. 3(3). 184–186. 23 indexed citations

11.

Mehta, Hemalkumar B., Kathleen M. Andersen, Omar Mansour, et al.. (2021). Use of Hydroxychloroquine, Remdesivir, and Dexamethasone Among Adults Hospitalized With COVID-19 in the United States. Annals of Internal Medicine. 174(10). 1395–1403. 24 indexed citations

12.

Fanai, Mehdi, Wei Fu, Zheyu Wang, et al.. (2021). Real-world virtual patient simulation to improve diagnostic performance through deliberate practice: a prospective quasi-experimental study. Diagnosis. 8(4). 489–496. 9 indexed citations

13.

Gerber, Jennifer E., et al.. (2021). Genomics in Patient Care and Workforce Decisions in High-Level Isolation Units: A Survey of Healthcare Workers. Health Security. 19(3). 318–326. 1 indexed citations

14.

Ignatius, Elisa H., Kunbo Wang, Andrew H. Karaba, et al.. (2020). Tocilizumab for the Treatment of COVID-19 Among Hospitalized Patients: A Matched Retrospective Cohort Analysis. Open Forum Infectious Diseases. 8(1). ofaa598–ofaa598. 20 indexed citations

15.

Garibaldi, Brian T., Pali D. Shah, Gigi Liu, et al.. (2020). Clinical course of COVID-19 in a liver transplant recipient on hemodialysis and response to tocilizumab therapy: A case report. American Journal of Transplantation. 20(8). 2254–2259. 35 indexed citations

16.

Russell, Stephen W., Sanjay V. Desai, Neera Ahuja, et al.. (2020). The genealogy of teaching clinical reasoning and diagnostic skill: the GEL Study. Diagnosis. 7(3). 197–203. 7 indexed citations

17.

Niessen, Timothy, et al.. (2020). Assessing physical examination skills using direct observation and volunteer patients. Diagnosis. 8(1). 101–110. 7 indexed citations

18.

Sauer, Lauren, et al.. (2020). The Risk of Not Being Ready: A Novel Approach to Managing Constant Readiness of a High-Level Isolation Unit During Times of Inactivity. Health Security. 18(3). 212–218. 3 indexed citations

19.

Goyal, Amit, et al.. (2019). Morning report innovation: Case Oriented Report and Exam Skills. Diagnosis. 6(2). 79–83. 6 indexed citations

20.

Aggarwal, Neil R., Franco R. D’Alessio, Yoshiki Eto, et al.. (2013). Macrophage A2A Adenosinergic Receptor Modulates Oxygen-Induced Augmentation of Murine Lung Injury. American Journal of Respiratory Cell and Molecular Biology. 48(5). 635–646. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact